It is important for the public to be aware of the scope of ovarian cancer, as over 80% of patients will experience a recurrence of the disease. Kunle Odunsi, MD, PhD, the Director of the University of Chicago Medicine Comprehensive Cancer Center and CRI Scientific Advisory Council associate director, is an expert on ovarian cancer and a titan in the field of cancer immunotherapy research.
Immune to Cancer: The CRI Blog
Patient Immunotherapy Summit: Ovarian Cancer Brief
For media inquiries, please contact us at [email protected]
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.
